Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Rheumatology | Nephrology | Family Medicine
Disease Category: Gout (Hyperuricemia)
Location: United States, NY
Cardiovascular / Gout
The purpose of this research study is to examine the long-term cardiovascular safety and effectiveness of an FDA approved and recently licensed medication (Uloric®/febuxostat) compared to another approved medication (Allopurinol) for preventative treatment of an acute attack of gout. All study related procedures, physical exams, and study medication are at no cost to you. You will be compensated $1,440 prorated at $30.00 per completed visit and $15.00 per completed phone call.
For more information and to see if you pre-qualify, please call our office at 585.288.0890 or visit our website at www.rcrclinical.com.
Rochester Clinical Research
500 Helendale Road, Suite L20
Rochester, NY 14609
Research Center Information: Rochester Clinical Research
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these